Curadis Competitors and Similar CompaniesClear all

Curadis's competitors and similar companies include Orexo, Imvax and Siloam.
Curadis
Curadis
Curadis is a company that develops medicines and therapy concepts for the treatment of hormone-dependent diseases and cancer.
Orexo
Orexo
Orexo, a specialty pharmaceutical company, engages in the development and commercialization of drugs.
Imvax
Imvax
Imvax is a biotechnology company that develops vaccines and immunotherapy strategies for the treatment of malignant gliomas and other cancers.
Siloam
Siloam
Siloam is a healthcare provider.
Founding Date
Founding Date
2015
Founding Date
1995
Founding Date
2015
Founding Date
1996
Type
Type
Private
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Erlangen, DE HQ
Locations
Uppsala, SE HQ
Uppsala, SE
Morristown, US
Locations
Philadelphia, US HQ
Locations
ID HQ
Employees
Employees
2
Employees
110
Employees
2723% decrease
Employees
14,616

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
kr26m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
Rp12.8t (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
kr14.5m (FY, 2025)
Cost of goods
N/A
Cost of goods
Rp7.7t (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
kr18m (FY, 2025)
Gross profit
N/A
Gross profit
Rp5.2t (FY, 2025)
Net income
Net income
N/A
Net income
(kr403.3m) (FY, 2025)
Net income
N/A
Net income
Rp1.2t (FY, 2025)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 72.9m
Total funding raised
$ 166.7m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Orexo
HQ
Uppsala, SE
Employees
110

Orexo, a specialty pharmaceutical company, engages in the development and commercialization of drugs.

View company
Imvax
HQ
Philadelphia, US
Employees
27↓ 23% decrease

Imvax is a biotechnology company that develops vaccines and immunotherapy strategies for the treatment of malignant gliomas and other cancers.

View company
Siloam
HQ
ID
Employees
14,616

Siloam is a healthcare provider.

View company